JP3044487B2 - Method for producing a composition containing sialic acids and having a high α-lactalbumin content - Google Patents
Method for producing a composition containing sialic acids and having a high α-lactalbumin contentInfo
- Publication number
- JP3044487B2 JP3044487B2 JP3055745A JP5574591A JP3044487B2 JP 3044487 B2 JP3044487 B2 JP 3044487B2 JP 3055745 A JP3055745 A JP 3055745A JP 5574591 A JP5574591 A JP 5574591A JP 3044487 B2 JP3044487 B2 JP 3044487B2
- Authority
- JP
- Japan
- Prior art keywords
- precipitate
- lactalbumin
- sialic acids
- resulting
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004407 Lactalbumin Human genes 0.000 title claims description 25
- 108090000942 Lactalbumin Proteins 0.000 title claims description 25
- 235000021241 α-lactalbumin Nutrition 0.000 title claims description 24
- 239000000203 mixture Substances 0.000 title claims description 20
- 125000005629 sialic acid group Chemical group 0.000 title claims description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 21
- 239000002244 precipitate Substances 0.000 claims description 21
- 102000007544 Whey Proteins Human genes 0.000 claims description 20
- 239000005862 Whey Substances 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 16
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- 235000013336 milk Nutrition 0.000 claims description 11
- 239000008267 milk Substances 0.000 claims description 11
- 210000004080 milk Anatomy 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000001471 micro-filtration Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 18
- 102000008192 Lactoglobulins Human genes 0.000 description 14
- 108010060630 Lactoglobulins Proteins 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 11
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000011575 calcium Substances 0.000 description 8
- 239000012466 permeate Substances 0.000 description 7
- 108010076119 Caseins Proteins 0.000 description 6
- 102000011632 Caseins Human genes 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 108010067454 caseinomacropeptide Proteins 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 235000020256 human milk Nutrition 0.000 description 5
- 210000004251 human milk Anatomy 0.000 description 5
- 108010058314 rennet Proteins 0.000 description 5
- 229940108461 rennet Drugs 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- 235000013351 cheese Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OIZGSVFYNBZVIK-FHHHURIISA-N 3'-sialyllactose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O OIZGSVFYNBZVIK-FHHHURIISA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- -1 CaCl 2 or MgCl 2 Chemical class 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 108010028463 kappa-casein glycomacropeptide Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 102000036068 sialic acid binding proteins Human genes 0.000 description 1
- 108091000315 sialic acid binding proteins Proteins 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000021246 κ-casein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Dairy Products (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、乳質ホエーからシアル
酸類を含有しα−ラクトアルブミン含有量の高い組成物
を製造する方法に関するものである。The present invention relates to a process for producing a composition containing sialic acids and having a high α-lactalbumin content from milky whey.
【0002】[0002]
【従来の技術】乳中に存在するシアル酸類には、例えば
シアリルラクトース(SL)の様な糖に結合したシアル
酸結合オリゴ糖、ペプチドに結合したκ−カゼイングリ
コマクロペプチド(GMP)、脂質に結合したガングリ
オシドなどがあることが従来より知られている。GMP
は、牛乳のκ−カゼインにレンネット又はペプシンを作
用させた時に生成するシアル酸結合ペプチドであって、
チーズホエー及びレンネットカゼインホエー中に含まれ
ている。2. Description of the Related Art Sialic acids present in milk include, for example, sialic acid-linked oligosaccharides linked to sugars such as sialyl lactose (SL), κ-casein glycomacropeptide (GMP) linked to peptides, and lipids. It is conventionally known that there is a ganglioside bound thereto. GMP
Is a sialic acid-binding peptide produced when rennet or pepsin is allowed to act on κ-casein of milk,
Included in cheese whey and rennet casein whey.
【0003】近年、糖蛋白質や糖脂質のような複合糖質
中に含まれている糖鎖が、生体における細胞間識別に重
要な役割を演ずることが知られ、シアル酸類はこの細胞
間識別を行うレセプターに必要な構成成分として特に重
要であることが認識されるようになってきている。ま
た、母乳中には牛乳に比べ3〜5倍程度のシアル酸類が
含まれており、このシアル酸類も乳児の感染防御因子の
一つとして機能するものと考えられている。特に、GM
Pには大腸菌の腸管細胞への付着を防止したり、インフ
ルエンザウイルスの感染を防御する効果(特開昭63-284
133)などのほか、抗歯垢効果(特開昭63-233911)や食欲
低下作用(Bulletin of Experimental Biology and Medi
cine 96,889(1983))があることが判ってきたことから、
これらを母乳代替品、機能性食品等の食品及び医薬品素
材として利用するための工業的規模での生産が強く望ま
れるようになってきた。In recent years, it has been known that sugar chains contained in complex carbohydrates such as glycoproteins and glycolipids play an important role in intercellular discrimination in living organisms. It has been recognized that it is particularly important as a necessary component for a receptor to perform. In addition, sialic acids are contained in breast milk in an amount about 3 to 5 times that of cow's milk, and these sialic acids are also considered to function as one of the protective factors for infection of infants. In particular, GM
P has an effect of preventing Escherichia coli from adhering to intestinal cells and protecting against influenza virus infection (JP-A-63-284).
133), anti-plaque effect (JP-A-63-233911) and anorexia (Bulletin of Experimental Biology and Medication)
cine 96,889 (1983))
There has been a strong demand for industrial-scale production for utilizing these as foods and pharmaceutical materials such as breast milk substitutes and functional foods.
【0004】これまでに乳中のシアル酸類を分別する技
術としては、シアル酸結合蛋白質の調製法(特公昭 40-
21234)、シアル酸結合オリゴ糖の調製法(特開昭59-184
197)およびシアル酸結合ペプチド(GMP)の調製法
(特開昭63-284199)等が示されている。一方、乳清蛋白
質はカゼイン及び大豆蛋白質に比べ栄養価、蛋白利用効
率が高いことから母乳代替品または栄養組成物の蛋白質
源として利用することが知られている。特に、母乳代替
品に利用する場合、牛乳中の乳清蛋白質の主成分である
β−ラクトグロブリンは、母乳に存在しない蛋白質であ
り、乳児アレルギーのアレルゲンとして作用することか
ら、α−ラクトアルブミン含有量の高い素材を利用する
ことが好ましいと言われている。As a technique for separating sialic acids in milk, a method for preparing a sialic acid binding protein (Japanese Patent Publication No.
21234), a method for preparing a sialic acid-linked oligosaccharide (JP-A-59-184)
197) and a method for preparing sialic acid-binding peptide (GMP) (JP-A-63-284199). On the other hand, whey protein is known to be used as a protein source in breast milk substitutes or nutritional compositions because it has higher nutritional value and protein utilization efficiency than casein and soy protein. In particular, when used as a substitute for breast milk, β-lactoglobulin, which is the main component of whey protein in milk, is a protein that does not exist in breast milk and acts as an allergen for infant allergies, containing α-lactalbumin. It is said that it is preferable to use a high amount of material.
【0005】これまでに、ホエーからα−ラクトアルブ
ミン含有量の高い画分を分離回収する方法としては、例
えば桑田ら(J.Food Sci.,50 (1985))、ピアス(Aust.D
airyTechnol.,42 (1987))及びモーブワら(特開昭56-36
494号公報) の方法等が示されている。しかしながら、
これらの方法はシアル酸類及びα−ラクトアルブミンを
個々に分別することを目的としており、乳中に含まれて
いるシアル酸類とα−ラクトアルブミンを同時に効率よ
く回収する方法を示していない。また、これらの方法は
工業的生産に際して工程が複雑となり、多額の設備投資
や高い運転コストとなる等、経済的に問題があった。As a method for separating and recovering a fraction having a high α-lactalbumin content from whey, there have been proposed, for example, Kuwata et al. (J. Food Sci., 50 (1985)) and Pierce (Aust. D.
airyTechnol., 42 (1987)) and Mowwa et al.
No. 494) is disclosed. However,
These methods aim at separating sialic acids and α-lactalbumin individually, and do not show a method for simultaneously and efficiently recovering sialic acids and α-lactalbumin contained in milk. In addition, these methods have economical problems, such as complicated processes in industrial production, large capital investment and high operating costs.
【0006】[0006]
【発明が解決しようとする課題】本発明は、近年このよ
うに有用性が認められるようになったシアル酸類及びα
−ラクトアルブミンを、チーズホエーまたはレンネット
カゼインホエーのような乳質ホエーから同時に効率よく
分離し、製造する方法を提供するものである。DISCLOSURE OF THE INVENTION The present invention relates to sialic acids and α-alpha acids which have recently been found to be useful.
To provide a method for simultaneously separating and producing lactalbumin efficiently and simultaneously from milky whey such as cheese whey or rennet casein whey.
【0007】[0007]
【課題を解決するための手段】本発明は、乳質ホエーを
冷却し、Ca及び/又はMgを添加後、pHを6〜9に調整
し、40〜60℃で10〜20分間加熱保持後、生成した沈澱物
を除去することを特徴とするシアル酸類を含有しα−ラ
クトアルブミン含有量の高い組成物の製造方法である。
更に詳しくは、本発明は、乳質ホエーを好ましくは0〜
10℃に冷却し、Ca及び/又はMg含量を好ましくは0.6 〜
2.0g/kg に調整し添加後、pHを6〜9に調整し、40〜60
℃で10〜20分間加熱保持後、生成した沈澱物を除去する
ことを特徴とする。この生成した沈澱物の除去に際し
て、孔径1μm以下の膜を用い、精密濾過処理を行う。
また或いは、分画分子量50000 以上の膜を用い、限外濾
過処理を行うこともできる。According to the present invention, milk whey is cooled, after adding Ca and / or Mg, the pH is adjusted to 6 to 9, and after heating and holding at 40 to 60 ° C. for 10 to 20 minutes , A method for producing a composition containing sialic acids and having a high α-lactalbumin content, which comprises removing a formed precipitate.
More particularly, the present invention relates to milk whey,
Cool to 10 ° C. and reduce the Ca and / or Mg content preferably from 0.6 to
After adjusting to 2.0 g / kg and adding, adjust the pH to 6-9 and add 40-60
After heating at 10 ° C. for 10 to 20 minutes, the formed precipitate is removed. When removing the formed precipitate, microfiltration is performed using a membrane having a pore size of 1 μm or less.
Alternatively, ultrafiltration can be performed using a membrane having a molecular weight cut-off of 50,000 or more.
【0008】また更には、膜処理にて得られた濾過液を
濃縮及び/又は脱塩し、更に必要に応じ乾燥粉末化する
こともできる。この濃縮脱塩に際してpHを4以上に調整
後、分画分子量50000 以下の膜を用い、限外濾過処理を
行うことができる。また更に好ましくは、α−ラクトア
ルブミン含量を高めるために、限外濾過処理にて得られ
た濃縮液をpH3.0 〜5.0 に調整後、40〜55℃で好ましく
は30〜60分加熱保持し、生成した沈澱物を得る。また、
更にpH6〜8に調整し沈澱物を溶解後、必要に応じ濃縮
・脱塩・乾燥粉末化することができる。Further, the filtrate obtained by the membrane treatment can be concentrated and / or desalted, and if necessary, can be made into a dry powder. After adjusting the pH to 4 or more during the concentration and desalting, ultrafiltration can be performed using a membrane having a molecular weight cut off of 50,000 or less. More preferably, in order to increase the α-lactalbumin content, the concentrated solution obtained by the ultrafiltration treatment is adjusted to pH 3.0 to 5.0, and then heated and maintained at 40 to 55 ° C., preferably for 30 to 60 minutes. The resulting precipitate is obtained. Also,
Further, after adjusting the pH to 6 to 8 and dissolving the precipitate, it can be concentrated, desalted, and dried to a powder as required.
【0009】本発明の原料であるシアル酸類を含有する
ホエーとは、牛乳、山羊乳、羊乳等の乳類からチーズ又
はレンネットカゼインを製造する際に副生されるもので
ある。これらホエーには、カードや脂肪が少量残存して
いることが多いので、一般にクリームセパレーター或い
はクラリファイヤー等でこれらを除去している。しかし
ながら、本発明によれば、このような処理を行うことな
く、精密濾過膜または限外濾過膜による処理を行うこと
によって脂肪を除去するとともに、β−ラクトグロブリ
ンを同時に除去することで蛋白質あたりのα−ラクトア
ルブミン含量を高めることができる。このようにして得
られた透過液はシアル酸類を含有し、且つα−ラクトア
ルブミンを高濃度に含んでいた。The whey containing sialic acids as a raw material of the present invention is produced as a by-product when producing cheese or rennet casein from milk such as cow's milk, goat's milk and sheep's milk. Since a small amount of curd or fat often remains in these whey, they are generally removed with a cream separator or a clarifier. However, according to the present invention, without performing such treatment, fat is removed by performing treatment with a microfiltration membrane or ultrafiltration membrane, and β-lactoglobulin is simultaneously removed by removing β-lactoglobulin. α-lactalbumin content can be increased. The permeate thus obtained contained sialic acids and α-lactalbumin at a high concentration.
【0010】本発明においてCa及びMg濃度の調整に用い
る物質は、CaCl2 、MgCl2 など水溶性の塩であれば何で
もよく、またpH調整に用いる物質は例えば酸であれば塩
酸、硫酸、酢酸等が、またアルカリであれば水酸化ナト
リウム、水酸化カリウム、水酸化カルシウム、炭酸カリ
ウム等が例示できる。Ca及び/又はMgを使用する理由は
β−ラクトグロブリンを以後の加熱保持工程で会合・凝
集させるためであり、Ca及び/又はMg含量を0.6 〜2.0g
/kg に調整する理由は、0.6g/kg 未満では遊離のCa及び
/又はMgのイオン強度が低いため、会合・凝集が充分に
進まず、また2.0g/kg を超え、イオン強度が高い場合
も、β−ラクトグロブリンの会合・凝集が低下するため
である。In the present invention, the substance used for adjusting the Ca and Mg concentrations may be any water-soluble salt such as CaCl 2 or MgCl 2, and the substance used for adjusting the pH may be, for example, an acid such as hydrochloric acid, sulfuric acid or acetic acid. And sodium hydroxide, potassium hydroxide, calcium hydroxide, potassium carbonate, and the like when they are alkalis. The reason for using Ca and / or Mg is to associate and agglutinate β-lactoglobulin in the subsequent heating and holding step, so that the content of Ca and / or Mg is 0.6 to 2.0 g.
The reason for adjusting to / kg is that if the ionic strength of free Ca and / or Mg is lower than 0.6 g / kg, the association / aggregation does not proceed sufficiently, and if it exceeds 2.0 g / kg and the ionic strength is higher. This is because the association and aggregation of β-lactoglobulin is reduced.
【0011】次いでpHを6〜9に調整し、40〜60℃で10
〜20分加熱するが、pHが6未満又はpHが9を超えるとβ
−ラクトグロブリンの会合・凝集が充分に起こらない。
また加熱時間と温度が上記範囲を超えるとα−ラクトア
ルブミン等の熱変性により、以後の精密濾過又は限外濾
過処理工程でβ−ラクトグロブリンとともに濃縮液に残
留し、透過液に目的の組成物を得ることができない。Then, the pH is adjusted to 6 to 9 and the temperature is adjusted to 10 at 40 to 60 ° C.
Heat for ~ 20 minutes, but if the pH is less than 6 or greater than 9,
-Lactoglobulin association / aggregation does not occur sufficiently.
Further, if the heating time and temperature exceed the above range, due to the thermal denaturation of α-lactalbumin, etc., it remains in the concentrate together with β-lactoglobulin in the subsequent microfiltration or ultrafiltration treatment step, and the permeated liquid contains the target composition. Can not get.
【0012】この精密濾過又は限外濾過処理工程で除去
される物質は、主に脂肪、β−ラクトグロブリンであ
り、一部血清アルブミン、免疫グロブリンも除去され
る。得られる組成物の成分は、乳清蛋白質として主にα
−ラクトアルブミンであり、またGMPを含むシアル酸
類、乳糖及び灰分を含んでいる。尚、Ca及びMg濃度によ
る乳清蛋白質の熱安定性に関しては、すでにスニサ・ヴ
ァルンサチアン(SUNISA VARUNSATIAN)らの方法(J.Food
Science,48 (1983))、ドウィット(J.N.deWIT) らの方法
(J.Dairy Science, 67(1984))等に示されているが、分
画方法としては遠心分離にて上清及び沈澱物を分画し、
またその分画物の組成を示しているに過ぎず、工業的な
膜を用いた分離・分画については述べていない。一方、
モーブワ(J.L.MAUBOIS) ら(Bulletin of the IDF212 (1
987)) は、精密濾過膜によるリポプロティンの除去方法
を示しているが、この操作によるβ−ラクトグロブリン
含量の変化については言及していない。The substances removed in this microfiltration or ultrafiltration step are mainly fats and β-lactoglobulin, and some serum albumins and immunoglobulins are also removed. The components of the resulting composition consist mainly of α as whey protein.
-Lactalbumin and also contains sialic acids, including GMP, lactose and ash. The thermal stability of whey proteins according to Ca and Mg concentrations has already been determined by the method of SUNISA VARUNSATIAN et al. (J. Food
Science, 48 (1983)), and the method of JNdeWIT et al. (J. Dairy Science, 67 (1984)). As a fractionation method, the supernatant and the precipitate are separated by centrifugation. Draw
It merely shows the composition of the fraction, but does not describe separation and fractionation using an industrial membrane. on the other hand,
Mulwa (JLMAUBOIS) et al. (Bulletin of the IDF212 (1
987)) shows a method for removing lipoprotein by a microfiltration membrane, but does not mention the change in β-lactoglobulin content by this operation.
【0013】このようにして得られた組成物は、乳糖含
量が高く蛋白質含量を高めた乳清蛋白濃縮物(WPC)
として用いる場合、次に限外濾過処理を行うことで必要
な蛋白質含量に調整することができる。この限外濾過処
理に際しては、シアル酸類を効率よく濃縮液に回収する
ために、pHを4以上に調整後、分画分子量50000 以下の
膜を用いることが好ましい。すなわちシアル酸類の主要
成分であるGMP(分子量約9000) はpH4以上ではポリ
マー(分子量50000)として存在し、一方pH4未満では、
モノマーとして存在することから濃縮液に効率よく回収
するためには、ポリマー化することが好ましい。[0013] The composition thus obtained comprises a whey protein concentrate (WPC) having a high lactose content and an increased protein content.
If used, the protein content can be adjusted to the required protein content by performing an ultrafiltration treatment. In the ultrafiltration treatment, it is preferable to use a membrane having a molecular weight cut-off of 50,000 or less after adjusting the pH to 4 or more in order to efficiently recover sialic acids into a concentrated solution. That is, GMP (molecular weight of about 9000), which is a main component of sialic acids, exists as a polymer (molecular weight of 50,000) at pH 4 or higher, while at a pH of less than 4,
Polymerization is preferred for efficient recovery in a concentrated solution since it exists as a monomer.
【0014】このようにして得られた濃縮液は、α−ラ
クトアルブミン含量をより高めるために、pH3.0〜5.0に
調整後、40〜55℃で好ましくは30〜60分加熱し、沈澱物
を生成する。この沈澱物はpH6〜8に調整し溶解後、必
要に応じ濃縮・脱塩・乾燥粉末化することもできる。こ
の沈澱生成工程において、前記範囲外では、シアル酸類
とα−ラクトアルブミンを沈澱物として同時に効率よく
回収することができない。The concentrate obtained in this manner is adjusted to pH 3.0 to 5.0 in order to further increase the α-lactalbumin content, and then heated at 40 to 55 ° C., preferably for 30 to 60 minutes, to obtain a precipitate. Generate The precipitate can be adjusted to pH 6 to 8 and dissolved, and then, if necessary, concentrated, desalted, and dried to a powder. In this precipitation generation step, outside the above range, sialic acids and α-lactalbumin cannot be simultaneously and efficiently recovered as a precipitate.
【0015】尚、この沈澱分画操作については、すでに
ピアス(R.J.PEARCE)ら(特表平2-503425公報) 、千原ら
( 特開昭63-268138 公報) によって示されているが、こ
れらの方法はα−ラクトアルブミンのみを分離・回収す
ることを目的としている。また本発明による方法は、こ
れらの方法とは前処理が異なっており、これらの工程に
よりシアル酸を含有し、且つα−ラクトアルブミンを同
時に効率良く回収することができる。Incidentally, the precipitation fractionation operation has already been described by Pierce (RJPEARCE) et al. (JP-A-2-503425) and Chihara et al.
As disclosed in Japanese Patent Application Laid-Open No. 63-268138, these methods aim at separating and recovering only α-lactalbumin. Further, the method according to the present invention is different from these methods in the pretreatment, and by these steps, sialic acid is contained and α-lactalbumin can be recovered simultaneously and efficiently.
【0016】[0016]
【発明の効果】本発明によれば、ホエーからシアル酸類
を含有し、且つα−ラクトアルブミンを高濃度に含有す
る組成物を工業的規模で安価に、且つ簡便に効率よく製
造することができる。このようにして得られた組成物
は、食品素材や医薬品素材として利用することが可能で
あり、産業界にとって極めて有益である。According to the present invention, a composition containing sialic acids from whey and a high concentration of α-lactalbumin can be produced on an industrial scale at low cost, easily and efficiently. . The composition thus obtained can be used as a food material or a pharmaceutical material, and is extremely useful for industry.
【0017】[0017]
【実施例】次に、実施例に基づき本発明を具体的に説明
する。 実施例1 チェダーチーズホエー100kg を殺菌後、2℃に冷却し、
CaCl2 を用いてCa濃度を1.2g/kg に調整する。次にNaOH
を用いてpHを7.3 に調整し、50℃で10分間加熱後、生成
した沈澱物は孔径0.2 μm の精密濾過膜(TECH-SEP CAR
BOSEP M20)を用いて除去し濃縮倍率20倍、等量加水倍率
1倍にて濾過した透過液100kg を得た。得られた透過液
は、固形 5.1g/100g、蛋白質 0.4g/100g、α−ラクトア
ルブミン0.08g/100g、β−ラクトグロブリン 0.07/100
g、シアル酸12mg/100g を含んでいた。Next, the present invention will be specifically described based on examples. Example 1 100 kg of cheddar cheese whey was sterilized and cooled to 2 ° C.
Adjust the Ca concentration to 1.2 g / kg with CaCl 2 . Then NaOH
After adjusting the pH to 7.3 using a, and heating at 50 ° C for 10 minutes, the resulting precipitate was filtered using a microfiltration membrane (TECH-SEP CARP
This was removed using BOSEP M20), and 100 kg of a permeate was obtained, which was filtered at a concentration ratio of 20 times and an equivalent water ratio of 1 time. The obtained permeate is solid 5.1 g / 100 g, protein 0.4 g / 100 g, α-lactalbumin 0.08 g / 100 g, β-lactoglobulin 0.07 / 100
g, sialic acid 12 mg / 100 g.
【0018】実施例2 実施例1で得られた透過液100kg をHCl を用いてpH5.5
に調整後、分画分子量20000Da の膜(DDS GR61PP)を用い
て濃縮倍率15倍の限外濾過処理を行い、濃縮液6.7kg を
得た。得られた濃縮液は、固形12.1g/100g、蛋白質 5.0
g/100g、α−ラクトアルブミン 1.2g/100g、β−ラクト
グロブリン 1.0g/100g、シアル酸175mg/100gを含んでい
た。Example 2 100 kg of the permeate obtained in Example 1 was converted to pH 5.5 using HCl.
After that, ultrafiltration was performed at a concentration of 15 times using a membrane having a molecular weight cut-off of 20,000 Da (DDS GR61PP) to obtain 6.7 kg of a concentrated solution. The resulting concentrate is a solid 12.1 g / 100 g, protein 5.0
g / 100 g, α-lactalbumin 1.2 g / 100 g, β-lactoglobulin 1.0 g / 100 g, and sialic acid 175 mg / 100 g.
【0019】実施例3 実施例2で得られた濃縮液6.7kg をHCl を用いてpH3.7
に調整後、55℃で30分間加熱し、生成した沈澱物を遠心
分離にて分離回収した。得られた沈澱物はNaOHを用いて
pH7 に調整溶解し組成物7.0kg を得た。得られた組成物
は、固形 2.6g/100g、蛋白質 2.0g/100g、α−ラクトア
ルブミン 1.0g/100g、β−ラクトグロブリン0.3g/100g
、シアル酸70mg/100g を含んでいた。Example 3 6.7 kg of the concentrate obtained in Example 2 was treated with HCl at pH 3.7.
Then, the mixture was heated at 55 ° C. for 30 minutes, and the formed precipitate was separated and collected by centrifugation. The resulting precipitate was washed with NaOH
It was adjusted to pH 7 and dissolved to obtain 7.0 kg of the composition. The obtained composition is solid 2.6 g / 100 g, protein 2.0 g / 100 g, α-lactalbumin 1.0 g / 100 g, β-lactoglobulin 0.3 g / 100 g.
Sialic acid at 70 mg / 100 g.
【0020】この組成物を常法により濃縮・乾燥して粉
末200gを得た。This composition was concentrated and dried by a conventional method to obtain 200 g of a powder.
【0021】実施例4 レンネットカゼインホエー100kg を殺菌後、2℃に冷却
しMgCl2 を用いてMg濃度を0.8g/kg に調整する。次にKO
H を用いてpHを7.3 に調整し、50℃で10分間加熱後、生
成した沈澱物は孔径0.5 μm の精密濾過膜(NGK CEFILT-
MF) を用いて除去し濃縮倍率25倍、等量加水倍率3倍に
て濾過し、透過液108kg を得た。得られた透過液は、固
形6.0g/100g 、蛋白質0.5g/100g 、α−ラクトアルブミ
ン0.10g/100g、β−ラクトグロブリン0.09/100g 、シア
ル酸16mg/100g を含んでいた。Example 4 100 kg of rennet casein whey was sterilized, cooled to 2 ° C., and the Mg concentration was adjusted to 0.8 g / kg with MgCl 2 . Then KO
After adjusting the pH to 7.3 with H and heating at 50 ° C for 10 minutes, the resulting precipitate was filtered through a 0.5 μm pore microfiltration membrane (NGK CEFILT-
MF) and filtered at a concentration ratio of 25 times and an equivalent water ratio of 3 times to obtain 108 kg of a permeate. The obtained permeate contained 6.0 g / 100 g of solid, 0.5 g / 100 g of protein, 0.10 g / 100 g of α-lactalbumin, 0.09 / 100 g of β-lactoglobulin, and 16 mg / 100 g of sialic acid.
【0022】実施例5 実施例4で得られた透過液108kg をHCl を用いてpH5.5
に調整後、分画分子量8000Daの膜(KOCH ABCOR HFK131)
を用いて濃縮倍率10倍の限外濾過処理を行い濃縮液10.8
kgを得た。得られた濃縮液は固形12.1g/100g、蛋白質
5.0g/100g、α−ラクトアルブミン 1.0g/100g、β−ラ
クトグロブリン 0.9g/100g、シアル酸150mg/100g を含
んでいた。Example 5 108 kg of the permeate obtained in Example 4 was converted to pH 5.5 using HCl.
After adjusting to 8000 Da membrane (KOCH ABCOR HFK131)
Ultrafiltration treatment of 10 times the concentration using a concentrated solution 10.8
kg gained. The resulting concentrate is 12.1 g / 100 g solid, protein
5.0 g / 100 g, α-lactalbumin 1.0 g / 100 g, β-lactoglobulin 0.9 g / 100 g, and sialic acid 150 mg / 100 g.
【0023】実施例6 実施例5で得られた濃縮液10.8kgをHCl を用いてpH4.0
に調整後、55℃で30分間加熱し生成した沈澱物を遠心分
離にて分離した。得られた沈澱物はNaOHを用いてpH7 に
調整溶解し組成物10.0kgを得た。得られた組成物は固形
2.4g/100g、蛋白質 1.8g/100g、α−ラクトアルブミン
1.0g/100g、β−ラクトグロブリン0.25g/100g、シアル
酸60mg/100g を含んでいた。Example 6 10.8 kg of the concentrate obtained in Example 5 was subjected to pH 4.0 using HCl.
After heating to 55 ° C. for 30 minutes, the resulting precipitate was separated by centrifugation. The resulting precipitate was adjusted to pH 7 with NaOH and dissolved to obtain 10.0 kg of a composition. The resulting composition is solid
2.4g / 100g, protein 1.8g / 100g, α-lactalbumin
It contained 1.0 g / 100 g, β-lactoglobulin 0.25 g / 100 g, and sialic acid 60 mg / 100 g.
【0024】この組成物を常法により濃縮・乾燥して粉
末250gを得た。This composition was concentrated and dried by a conventional method to obtain 250 g of a powder.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 菅原 牧裕 埼玉県川越市新宿町5−11−3 雪印乳 業株式会社独身寮 (72)発明者 松岡 康浩 埼玉県所沢市宮本町1−6−2 カナデ ィアンハイツ201 (56)参考文献 特開 平1−165343(JP,A) (58)調査した分野(Int.Cl.7,DB名) A23J 3/08 A23C 9/142 A23J 1/20 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Makihiro Sugawara 5-11-3 Shinjuku-cho, Kawagoe-shi, Saitama Snow Brand Milk Industry Co., Ltd. Single dormitory (72) Inventor Yasuhiro Matsuoka 1-6, Miyamoto-cho, Tokorozawa-shi, Saitama 2 Canadian Heights 201 (56) References JP-A-1-165343 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A23J 3/08 A23C 9/142 A23J 1/20
Claims (2)
加後、pHを6〜9に調整し、40〜60℃で10〜20分間加熱
保持後、孔径1μm以下の膜を用い、精密濾過処理を行
って生成した沈澱物を除去し、得られた濾過液のpHを4
以上に調整後、分画分子量50000 以下の膜を用い、限外
濾過処理を行い、得られた濃縮液をpH3.0 〜5.0 に調整
後、40〜55℃で30〜60分加熱保持後、生成した沈澱物を
得、さらにpH6〜8に調整し、沈澱物を溶解後、必要に
応じ濃縮・脱塩・乾燥粉末化することを特徴とするシア
ル酸類を含有し同時にα−ラクトアルブミン含有量の高
い組成物の製造方法。1. Cooling milk whey, adding Ca and / or Mg, adjusting the pH to 6 to 9, heating and holding at 40 to 60 ° C. for 10 to 20 minutes , and using a membrane having a pore size of 1 μm or less, Perform microfiltration
The resulting precipitate was removed, and the resulting filtrate was adjusted to pH 4
After adjustment as above, use a membrane with a molecular weight cut off of 50,000 or less,
Perform filtration and adjust the resulting concentrate to pH 3.0 to 5.0
Thereafter, after heating and holding at 40 to 55 ° C for 30 to 60 minutes, the formed precipitate is removed.
And further adjusted to pH 6-8, and after dissolving the precipitate,
A method for producing a composition containing sialic acids and having a high content of α-lactalbumin at the same time , characterized in that the composition is concentrated, desalted and dried to obtain a powder .
加後、pHを6〜9に調整し、40〜60℃で10〜20分間加熱
保持後、分画分子量50000 以上の膜を用い、限外濾過処
理を行って生成した沈澱物を除去し、得られた濾過液の
pHを4以上に調整後、分画分子量50000 以下の膜を用
い、限外濾過処理を行い、得られた濃縮液をpH3.0 〜5.
0 に調整後、40〜55℃で30〜60分間加熱保持後、生成し
た沈澱物を得、さらにpH6〜8に調整し、沈澱物を溶解
後、必要に応じ濃縮・脱塩・乾燥粉末化することを特徴
とするシアル酸類を含有し同時にα−ラクトアルブミン
含有量の高い組成物の製造方法。2. Milk whey is cooled, and Ca and / or Mg is added.
After addition, adjust the pH to 6-9 and heat at 40-60 ° C for 10-20 minutes
After retention, use an ultrafiltration
The resulting precipitate was removed by filtration and the resulting filtrate was filtered.
After adjusting the pH to 4 or more, use a membrane with a molecular weight cut off of 50,000 or less.
Ultrafiltration was performed, and the resulting concentrated solution was adjusted to pH 3.0 to 5.
After adjusting to 0, heating and holding at 40-55 ° C for 30-60 minutes,
The precipitate obtained was adjusted to pH 6-8, and the precipitate was dissolved.
Afterwards, if necessary, it is concentrated, desalted, and dried into powder
Α-lactalbumin containing sialic acids
A method for producing a composition having a high content .
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3055745A JP3044487B2 (en) | 1991-02-28 | 1991-02-28 | Method for producing a composition containing sialic acids and having a high α-lactalbumin content |
NZ241741A NZ241741A (en) | 1991-02-28 | 1992-02-26 | A process for preparing a high alpha-lactalbumin and sialic acid composition from milk whey |
FR9202223A FR2673359B1 (en) | 1991-02-28 | 1992-02-26 | PROCESS FOR PRODUCING A HIGH ALPHA-LACTALBUMIN COMPOSITION CONTAINING SIALIC ACIDS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3055745A JP3044487B2 (en) | 1991-02-28 | 1991-02-28 | Method for producing a composition containing sialic acids and having a high α-lactalbumin content |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05276876A JPH05276876A (en) | 1993-10-26 |
JP3044487B2 true JP3044487B2 (en) | 2000-05-22 |
Family
ID=13007396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3055745A Expired - Fee Related JP3044487B2 (en) | 1991-02-28 | 1991-02-28 | Method for producing a composition containing sialic acids and having a high α-lactalbumin content |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP3044487B2 (en) |
FR (1) | FR2673359B1 (en) |
NZ (1) | NZ241741A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019189350A1 (en) | 2018-03-30 | 2019-10-03 | 雪印メグミルク株式会社 | METHOD FOR PRODUCING COMPOSITION CONTAINING κ-CASEIN GLYCOMACROPEPTIDE |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875459B2 (en) | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
JP2009514511A (en) * | 2005-11-04 | 2009-04-09 | アルラ フーズ アンバ | Concentrated natural sialyl lactose, concentrate derived from dairy products, and preparation method thereof |
EP2007213A4 (en) * | 2006-03-23 | 2011-07-06 | Fonterra Co Operative Group | Method for preparing a dried modified whey protein |
JP6932687B2 (en) * | 2016-03-07 | 2021-09-08 | 雪印メグミルク株式会社 | Whey protein fractionation method, method for producing a composition containing α-lactalbumin, and method for producing a composition containing β-lactoglobulin. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2325329A2 (en) * | 1975-09-26 | 1977-04-22 | Manche Union Coop Agricol Lait | Sialic acids and glycoproteins from lactoserum from cheese making - with improved spen. and higher yield |
FR2459619B1 (en) * | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | PROCESS FOR OBTAINING FROM LACTOSERUM, A PRODUCT ENRICHED IN ALPHA-LACTALBUMIN AND APPLICATIONS OF SAID PROCESS |
JP2631470B2 (en) * | 1987-05-15 | 1997-07-16 | 雪印乳業株式会社 | Infection protective agent |
-
1991
- 1991-02-28 JP JP3055745A patent/JP3044487B2/en not_active Expired - Fee Related
-
1992
- 1992-02-26 FR FR9202223A patent/FR2673359B1/en not_active Expired - Lifetime
- 1992-02-26 NZ NZ241741A patent/NZ241741A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019189350A1 (en) | 2018-03-30 | 2019-10-03 | 雪印メグミルク株式会社 | METHOD FOR PRODUCING COMPOSITION CONTAINING κ-CASEIN GLYCOMACROPEPTIDE |
Also Published As
Publication number | Publication date |
---|---|
JPH05276876A (en) | 1993-10-26 |
FR2673359A1 (en) | 1992-09-04 |
NZ241741A (en) | 1993-11-25 |
FR2673359B1 (en) | 2001-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8889208B2 (en) | Purification of beta casein from milk | |
JP2673828B2 (en) | Method for producing κ-casein glycomacropeptide | |
US6613377B2 (en) | Whey treatment process for achieving high concentration of α-lactalbumin | |
JP2622789B2 (en) | Method for producing a fraction having a high content of α-lactalbumin from whey and breast milk substitute or nutritional composition containing said fraction | |
US20040234666A1 (en) | Method of extracting casein fractions from milk and caseinates and production of novel products | |
JPH04198198A (en) | Production of kappa-casein glycomacropeptide | |
JPH02503425A (en) | whey protein fraction | |
JP2881044B2 (en) | Method for producing kappa-caseino-glycomacropeptide | |
JPH04316450A (en) | Production of composition containing sialic acid | |
JP2961625B2 (en) | Method for producing a composition having a high content of α-lactalbumin | |
JP3044487B2 (en) | Method for producing a composition containing sialic acids and having a high α-lactalbumin content | |
WO1994015952A1 (en) | Method for production of a kappa-casein glycomacropeptide and use of a kappa-casein glycomacropeptide | |
JPH10501698A (en) | Method for separating whey ingredients | |
JPH01168693A (en) | Production of composition containing sialic acids | |
JP3225080B2 (en) | Method for producing a composition having a high content of kappa-casein glycomacropeptide | |
JPH03240437A (en) | Prepared milk resemble to human milk | |
JP3176698B2 (en) | Method for producing ganglioside-containing composition | |
JP3225081B2 (en) | Method for producing a composition having a high content of kappa-casein glycomacropeptide | |
JP3152977B2 (en) | Milk protein material containing casein protein similar to human milk and method for producing the same | |
JP2900953B2 (en) | Process for producing a milk fraction having a high content of α-lactalbumin and a product containing the fraction | |
JP3411965B2 (en) | Method for producing polyamine-containing composition | |
US20020183489A1 (en) | Large scale production of low fat and SDS gel pure kappa-casein glycomacropeptides (GMP) from bovine deproteinzed whey | |
JP2985157B2 (en) | Method for fractionating casein into α-casein and β-casein | |
IE920012A1 (en) | Process for the separation of whey proteins and products¹obtained | |
JP3029684B2 (en) | Production method of milk fraction having high content of α-lactalbumin by ultrafiltration method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090317 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |